{"name":"Daehwa Pharmaceutical Co., Ltd.","slug":"daehwa-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DHP107","genericName":"DHP107","slug":"dhp107","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DHP1401","genericName":"DHP1401","slug":"dhp1401","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"DHP107","genericName":"DHP107","slug":"dhp107","phase":"phase_2","mechanism":"DHP107 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""},{"name":"DHP1401","genericName":"DHP1401","slug":"dhp1401","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE12eDIyTXJzODlrc2lsXzVlWUhGbXVselN1SjJXQnNTOEt1bkNQYjkyV3F0SWpKWDNFc2J6bWRIOExBa3dvR1BFZk5KNm5SRnVucGM4ZG42V0QybW45a1VCNEhDYUlxLUgzb2YycHNR0gFyQVVfeXFMTVBnamVfYUI2NmhDSUg1ZTcyREFIUU9UNGlNX0tlSHUtWmpmR0pNVkZULTZXNllDREtNa1ZBTFVkRk9ZRXV0a0ItYnotT29wQzFacWNRaGxPcFdEYVJhbmotUUIzOFFpNTlvYXp6QTRYaVBB?oc=5","date":"2025-05-28","type":"pipeline","source":"koreabiomed.com","summary":"Next-gen Korean cancer fighters to showcase innovation at ASCO 2025 - koreabiomed.com","headline":"Next-gen Korean cancer fighters to showcase innovation at ASCO 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"PR Newswire","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - PR Newswire","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-10-02","type":"regulatory","source":"GlobeNewswire","summary":"SERD Market is Predicted to Exhibit Remarkable Growth Owing - GlobeNewswire","headline":"SERD Market is Predicted to Exhibit Remarkable Growth Owing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZ1R2OG0yX293dnl5YVhwS3UtcmtBQ0wzaFFFMVZBcVA0TmFZQnFJUXNKYjBNVEJoMkE1dlFjcXRVRTNhSk8tLUgzZjl3MkJMZFJIOTV4QzdhVWJMUmtqZXQwai1QLXVqNk50cUF4TkJtaDlUOHdkaUFtM3Ixak4tYm5JRjl5VHVJaHloSFFYN25RTkM5S2NvOWlIT250bDA5MEloU2phQm5TZklCdEFzQ2c3ZGdfWHF0eThURTMyOW1LSXRzVGpOaENhWFBzVHNyRzlEamp1RU96bW5vZWc0?oc=5","date":"2024-09-25","type":"pipeline","source":"PR Newswire","summary":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight - PR Newswire","headline":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE0wQmxudXEwWmtiVk95emVDbHpCMFVGd0MwNHR1TFVaSW1FVEJ4UnJFLTFzN2hKams0QkxlVnJGWVZzZVRoSHhCYTV5MGxQOHJZdFhrMWstZlIyd3dKU3RkaVVCOWJvRU9UVi1iQmtR?oc=5","date":"2023-10-18","type":"trial","source":"KED Global","summary":"Humedix gets gov't OK for trials of dementia candidate drug - KED Global","headline":"Humedix gets gov't OK for trials of dementia candidate drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1oODQ5N1pIdTktYkdIZFpSb3lLQno3dEhjUkd2MWFsRnVwYzBGa183ZnFlWk9GSFJzY3FSWUxJTGx1dXlNZ0U3RVMxZHU2SGpKMFJSaUFxWHNTR0VTWUVncGFoam5LQkxEU19qYTVR?oc=5","date":"2023-06-16","type":"regulatory","source":"KED Global","summary":"Daehwa Pharm applies for approval of anti-dementia patch in China - KED Global","headline":"Daehwa Pharm applies for approval of anti-dementia patch in China","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE02SHhtcTV6UTU3VEg0MkFiSWZQbGpiMXJSVzZBWHZldmtYUXNZSzlVZmR4SUJKVEJHU1BsOXptVHZQTjkxZ3RiVTZMUTZOLWhDY1MzZjBxOVc0UFRVVUJyag?oc=5","date":"2020-08-03","type":"pipeline","source":"Pharmaceutical Executive","summary":"Country Report: Korea - Pharmaceutical Executive","headline":"Country Report: Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQbVRham1hXzhUalZqaVR3R0tlZkJPNHQ3M1lvbV9HOC1GMmxOOE5TZDRQRHdQaWVhUThWRnktdVJ3bi1jLURyeXBzcW13cGM2OVo2QnVuUnJ1QUUzai12NzlQVXowT2pmVENXWFdUWmJiRVBqTVQ1VEE3bjB6SDFXSUdMQlY2TUlOSkh3Y25oUEVfOEpoOGc?oc=5","date":"2013-09-13","type":"pipeline","source":"BioSpectrum Asia","summary":"0 - BioSpectrum Asia","headline":"0","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}